Article
Discovery of CFTR modulators for the treatment of cystic fibrosis.
Expert opinion on drug discovery - 1 Aug 2021
Lopes-Pacheco Miquéias, Pedemonte Nicoletta, Veit Guido
Abstract excerpt
INTRODUCTION: Cystic fibrosis (CF) is a life-threatening inherited disease caused by mutations in the gene encoding the CF transmembrane conductance regulator (CFTR) protein, an anion channel expressed at the apical membrane of secretory epithelia. CF leads to multiorgan dysfunction with progressive deterioration of lung function being the major cause of untimely death. Conventional CF therapies target only...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
